ConductScience.org, home

Paper · 17848629

GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.

McClean PL and 5 others. Am J Physiol Endocrinol Metab, 2007. Cited by 214 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Papers, record 17848629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17848629

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
PubMed
Journal
Am J Physiol Endocrinol Metab
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
214
iCite
Relative citation ratio, by iCite
5.16
iCite
Revised in PubMed
2022-03-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McClean PLPaula L
2Irwin NNigel
3Cassidy RSRoslyn S
4Holst JJJens J
5Gault VAVictor A
6Flatt PRPeter R

Source PubMed

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastric Inhibitory PolypeptideMajor topic
Insulin ResistanceMajor topic
ObesityMajor topic
Receptors, Gastrointestinal HormoneMajor topic
Adipokines
Adipose Tissue
Animals
Anti-Obesity Agents
Blood Glucose
Body Weight
Corticosterone
Dietary Fats
Eating
Glucagon
Glucagon-Like Peptide 1
Glucose Intolerance
Incretins
Insulin
Lipids
Liver
Male
Mice
Motor Activity
Muscle, Skeletal
Pancreas

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by96

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.

PMIDTitleJournalYearIn PapersSource
42,683,151Tirzepatide for obesity without diabetes: mechanistic insights, clinical evidence, and future directions.Front Pharmacol2026https://conductscience.org/library/papers/42683151PubMed
42,592,044Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.Antib Ther2026https://conductscience.org/library/papers/42592044PubMed
42,240,123Recent developments in GPCR signalling in appetite regulation.Biosci Rep2026https://conductscience.org/library/papers/42240123PubMed
41,679,433GIPR signaling modulates PYY-induced hypophagia and malaise in rodents.Mol Metab2026https://conductscience.org/library/papers/41679433PubMed
40,806,228Associations of Serum GIP, GLP-1, and DPP-4 with Metabolic and Hormonal Profiles and Tobacco Exposure in Women with Polycystic Ovary Syndrome.Int J Mol Sci2025https://conductscience.org/library/papers/40806228PubMed
40,347,281
Impact of chronic consumption of probiotics, oats, and apples on expression of genes related to bile acids, lipid, gut peptides, and inflammation in peripheral monocular cells - findings from the CABALA study.
Eur J Nutr2025https://conductscience.org/library/papers/40347281PubMed
40,214,973Hormonal predictors of the insulin sensitive phenotype in humans.Biomol Biomed2025https://conductscience.org/library/papers/40214973PubMed
40,201,698The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis.Front Pharmacol2025https://conductscience.org/library/papers/40201698PubMed
40,175,127Physiology and clinical applications of GIP.Endocr J2025https://conductscience.org/library/papers/40175127PubMed
40,166,681The role of GIPR in food intake control.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40166681PubMed

1 to 10 of 96

See all 96 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17848629

GET https://conductscience.org/api/papers/v1/17848629/cited_by?page=2